Differential Roles for Endothelial ICAM-1, ICAM-2, and VCAM-1 in Shear-Resistant T Cell Arrest, Polarization, and Directed Crawling on Blood-Brain Barrier Endothelium

Theodor Kocher Institute, University of Bern, Bern, Switzerland.
The Journal of Immunology (Impact Factor: 5.36). 10/2010; 185(8):4846-55. DOI: 10.4049/jimmunol.0903732
Source: PubMed

ABSTRACT Endothelial ICAM-1 and ICAM-2 were shown to be essential for T cell diapedesis across the blood-brain barrier (BBB) in vitro under static conditions. Crawling of T cells prior to diapedesis was only recently revealed to occur preferentially against the direction of blood flow on the endothelial surface of inflamed brain microvessels in vivo. Using live cell-imaging techniques, we prove that Th1 memory/effector T cells predominantly crawl against the direction of flow on the surface of BBB endothelium in vitro. Analysis of T cell interaction with wild-type, ICAM-1-deficient, ICAM-2-deficient, or ICAM-1 and ICAM-2 double-deficient primary mouse brain microvascular endothelial cells under physiological flow conditions allowed us to dissect the individual contributions of endothelial ICAM-1, ICAM-2, and VCAM-1 to shear-resistant T cell arrest, polarization, and crawling. Although T cell arrest was mediated by endothelial ICAM-1 and VCAM-1, T cell polarization and crawling were mediated by endothelial ICAM-1 and ICAM-2 but not by endothelial VCAM-1. Therefore, our data delineate a sequential involvement of endothelial ICAM-1 and VCAM-1 in mediating shear-resistant T cell arrest, followed by endothelial ICAM-1 and ICAM-2 in mediating T cell crawling to sites permissive for diapedesis across BBB endothelium.

Download full-text


Available from: Ruth Lyck, Jul 07, 2015
1 Follower
  • Source
    • "Both DC-SIGNR and DC-SIGN lectins are expressed on sinusoidal endothelial cells and recognize the Lewis sugars (Lai et al., 2006). ICAM-2 is normally glycosylated with Lewis(Y), and is involved in T-cell recruitment across activated brain endothelial cells (Steiner et al., 2010). Lewis(Y) binds to DC-SIGN, and it has been suggested that the interaction between ICAM-2 and DC-SIGN is an early event in dendritic cell recruitment to the CNS (Arjmandi et al., 2009). "
  • Source
    • "For in vitro chemokine transcytosis, pMBMECs were isolated from brains of DARC-deficient and wild-type SJL mice at 6–8 weeks of age, as described (Steiner et al., 2010). pMBMECs plated on Matrigel (BD Biosciences) coated 0.4 mm pore size transwell filters (Corning; Vitaris AG) and cultured for 6 days to reach confluency. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The Duffy antigen/receptor for chemokines, DARC, belongs to the family of atypical heptahelical chemokine receptors that do not couple to G proteins and therefore fail to transmit conventional intracellular signals. Here we show that during experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis, the expression of DARC is upregulated at the blood-brain barrier. These findings are corroborated by the presence of a significantly increased number of subcortical white matter microvessels staining positive for DARC in human multiple sclerosis brains as compared to control tissue. Using an in vitro blood-brain barrier model we demonstrated that endothelial DARC mediates the abluminal to luminal transport of inflammatory chemokines across the blood-brain barrier. An involvement of DARC in experimental autoimmune encephalomyelitis pathogenesis was confirmed by the observed ameliorated experimental autoimmune encephalomyelitis in Darc(-/-) C57BL/6 and SJL mice, as compared to wild-type control littermates. Experimental autoimmune encephalomyelitis studies in bone marrow chimeric Darc(-/-) and wild-type mice revealed that increased plasma levels of inflammatory chemokines in experimental autoimmune encephalomyelitis depended on the presence of erythrocyte DARC. However, fully developed experimental autoimmune encephalomyelitis required the expression of endothelial DARC. Taken together, our data show a role for erythrocyte DARC as a chemokine reservoir and that endothelial DARC contributes to the pathogenesis of experimental autoimmune encephalomyelitis by shuttling chemokines across the blood-brain barrier.
    Brain 03/2014; 137(5). DOI:10.1093/brain/awu045 · 10.23 Impact Factor
  • Source
    • "M ) - 1 , ICAM - 2 , vascular CAM ( VCAM ) - 1 , activated leukocyte CAM ( ALCAM ) , melanoma CAM ( MCAM ) , and ninjurin - 1 which mediate , at least in part , the adhesion process and transmigration of leukocytes and leukocyte subtypes to the CNS ( Cayrol et al . , 2008 ; Ifergan et al . , 2011 ; Larochelle et al . , 2012 ; Prat et al . , 2000 ; Steiner et al . , 2010 ; Wong and Dorovini - Zis , 1992 ) ( Fig . 5 ) . Additional effectors of leukocyte diapedesis include platelet endothelial cell adhesion molecule ( PECAM ) ( Williams et al . , 1996 ) , JAM - A ( Ostermann et al . , 2002 ) , CD73 and vascular associated protein - 1 ( VAP - 1 ) ( Jal - kanen and Salmi , 2008 ) ( Fig . 5 ) but their role "
    [Show abstract] [Hide abstract]
    ABSTRACT: The Blood Brain Barrier (BBB) is a specialized vascular structure tightly regulating central nervous system (CNS) homeostasis. Endothelial cells are the central component of the BBB and control of their barrier phenotype resides on astrocytes and pericytes. Interactions between these cells and the endothelium promote and maintain many of the physiological and metabolic characteristics that are unique to the BBB. In this review we describe recent findings related to the involvement of astroglial cells, including radial glial cells, in the induction of barrier properties during embryogenesis and adulthood. In addition, we describe changes that occur in astrocytes and endothelial cells during injury and inflammation with a particular emphasis on alterations of the BBB phenotype. GLIA 2013.
    Glia 12/2013; 61(12). DOI:10.1002/glia.22575 · 6.03 Impact Factor